Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells

Immunology Letters

Volumn 118, Issue 2, 2008, Pages 132-141

  Kimbrell, Matthew R ^a   Warshakoon, Hemamali ^a   Cromer, Jens R ^a   Malladi, Subbalakshmi ^a   Hood, Jennifer D ^a   Balakrishna, Rajalakshmi ^a   Scholdberg, Tandace A ^a   David, Sunil A ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Innate immunity; Lipopeptides; Lipoteichoic acid; Peptidoglycan; Sepsis; Septic shock

Indexed keywords

CD11B ANTIGEN; CHEMOKINE; CYTOKINE; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; CELL ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GRAM POSITIVE BACTERIUM; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; LEUKOCYTE ACTIVATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PLASMA PROTEIN BINDING; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BLOOD CELLS; CELL LINE; CELLS; ENDOTOXINS; GRAM-POSITIVE BACTERIA; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MACROPHAGES; MICE; PEPTIDOGLYCAN; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2;

EID: 44649203299     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.03.009     Document Type: Article

References (48)

1. Centers for Diseases Control. Increases in national hospital discharge survey rates for septicemia, United States, 1979-1987. MMWR 1990;39:31-4.
2. Moss M., and Martin G.S. A global perspective on the epidemiology of sepsis. Intensive Care Med 30 (2004) 527-529
3. Cross A., and Opal S.M. Therapeutic intervention in sepsis with antibody to endotoxin: is there a future?. J Endotoxin Res 1 (1994) 57-59
4. Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8 (1994) 217-225
5. Galanos C., Lüderitz O., Rietschel E.T., Westphal O., Brade H., Brade L., et al. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem 148 (1985) 1-5
6. Bone R.C. Gram-positive organisms and sepsis. Arch Intern Med 154 (1994) 26-34
7. Safdar A., Rodriguez G.H., Balakrishnan M., Tarrand J.J., and Rolston K.V. Changing trends in etiology of bacteremia in patients with cancer. Eur J Clin Microbiol Infect Dis 25 (2006) 522-526
8. Bone R.C. How gram-positive organisms cause sepsis. J Crit Care 8 (1993) 51-59
9. Elson G., Dunn-Siegrist I., Daubeuf B., and Pugin J. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 109 (2007) 1574-1583
10. Nguyen T.B., Adisechan A., Suresh Kumar E.V.K., Balakrishna R., Kimbrell M.R., Miller K.A., et al. Protection from Endotoxic Shock by EVK-203, a Novel Alkylpolyamine Sequestrant of Lipopolysaccharide. Bioorg Med Chem 15 (2007) 5694-5709
11. Sil D., Shrestha A., Kimbrell M.R., Nguyen T.B., Adisechan A.K., Balakrishna R., et al. Bound to shock: protection from lethal endotoxemic shock by a novel, nontoxic, alkylpolyamine lipopolysaccharide sequestrant. Antimicrob Agents Chemother 51 (2007) 2811-2819
12. Vollmer W., and Holtje J.V. The architecture of the murein (peptidoglycan) in gram-negative bacteria: vertical scaffold or horizontal layer(s)?. J Bacteriol 186 (2004) 5978-5987
13. Baddiley J. Bacterial cell walls and membranes. Discovery of the teichoic acids. Bioessays 10 (1989) 207-210
14. Fischer W. Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus. Med Microbiol Immunol 183 (1994) 61-76
15. Henderson B., Poole S., and Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 60 (1996) 316-341
16. Muhlradt P.F., Kiess M., Meyer H., Sussmuth R., and Jung G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med 185 (1997) 1951-1958
17. Dziarski R., and Gupta D. The peptidoglycan recognition proteins (PGRPs). Genome Biol 7 (2006) 232
18. Schroder N.W., Morath S., Alexander C., Hamann L., Hartung T., Zahringer U., et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 278 (2003) 15587-15594
19. Buwitt-Beckmann U., Heine H., Wiesmuller K.H., Jung G., Brock R., and Ulmer A.J. Lipopeptide structure determines TLR2 dependent cell activation level. FEBS J 272 (2005) 6354-6364
20. Nahori M.A., Fournie-Amazouz E., Que-Gewirth N.S., Balloy V., Chignard M., Raetz C.R., et al. Differential TLR recognition of leptospiral lipid A and lipopolysaccharide in murine and human cells. J Immunol 175 (2005) 6022-6031
21. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
22. Akira S., and Takeda K. Functions of toll-like receptors: lessons from KO mice. C R Biol 327 (2004) 581-589
23. Burns M.R., Wood S.J., Miller K.A., Nguyen T., Cromer J.R., and David S.A. Lysine-spermine conjugates: hydrophobic polyamine amides as potent lipopolysaccharide sequestrants. Bioorg Med Chem 13 (2005) 2523-2536
24. Gao J.J., Xue Q., Zuvanich E.G., Haghi K.R., and Morrison D.C. Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro. Infect Immun 69 (2001) 751-757
25. Bhattacharjya S., David S.A., Mathan V.I., Balaram P., and Polymyxin. B nonapeptide: conformations in water and in the lipopolysaccharide-bound state determined by two-dimensional NMR and molecular dynamics. Biopolymers 41 (1997) 251-265
26. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169 (2002) 10-14
27. Okusawa T., Fujita M., Nakamura J., Into T., Yasuda M., Yoshimura A., et al. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6. Infect Immun 72 (2004) 1657-1665
28. Jin M.S., Kim S.E., Heo J.Y., Lee M.E., Kim H.M., Paik S.G., et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130 (2007) 1071-1082
29. Buwitt-Beckmann U., Heine H., Wiesmuller K.H., Jung G., Brock R., Akira S., et al. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem 281 (2006) 9049-9057
30. Ehl S., Bischoff R., Ostler T., Vallbracht S., Schulte-Monting J., Poltorak A., et al. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur J Immunol 34 (2004) 1146-1153
31. Wilde I., Lotz S., Engelmann D., Starke A., van Zandbergen G., Solbach W., et al. Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes. Med Microbiol Immunol 196 (2007) 61-71
32. Stadelmaier A., Morath S., Hartung T., and Schmidt R.R. Synthesis of the first fully active lipoteichoic acid. Angew Chem Int Ed Engl 42 (2003) 916-920
33. Byrd-Leifer C.A., Block E.F., Takeda K., Akira S., and Ding A. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol. Eur J Immunol 31 (2001) 2448-2457
34. Bryant C.E., Ouellette A., Lohmann K., Vandenplas M., Moore J.N., Maskell D.J., et al. The cellular Toll-like receptor 4 antagonist E5531 can act as an agonist in horse whole blood. Vet Immunol Immunopathol 116 (2007) 182-189
35. Omueti K.O., Beyer J.M., Johnson C.M., Lyle E.A., and Tapping R.I. Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. J Biol Chem 280 (2005) 36616-36625
36. Picard C., Puel A., Bonnet M., Ku C.L., Bustamante J., Yang K., et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299 (2003) 2076-2079
37. O'Neill L.A., and Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7 (2007) 353-364
38. Spiller S., Dreher S., Meng G., Grabiec A., Thomas W., Hartung T., et al. Cellular recognition of trimyristoylated peptide or enterobacterial lipopolysaccharide via both TLR2 and TLR4. J Biol Chem 282 (2007) 13190-13198
39. Levels J.H., Abraham P.R., van Barreveld E.P., Meijers J.C., and van Deventer S.J. Distribution and kinetics of lipoprotein-bound lipoteichoic acid. Infect Immun 71 (2003) 3280-3284
40. Mattsson E., Hartung T., Morath S., and Egesten A. Highly purified lipoteichoic acid from Staphylococcus aureus induces procoagulant activity and tissue factor expression in human monocytes, but is a weak inducer in whole blood: comparison with peptidoglycan. Infect Immun 72 (2004) 4322-4326
41. Hashimoto M., Furuyashiki M., Kaseya R., Fukada Y., Akimaru M., Aoyama K., et al. Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction. Infect Immun 75 (2007) 1926-1932
42. Tattoli I., Travassos L.H., Carneiro L.A., Magalhaes J.G., and Girardin S.E. The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation. Semin Immunopathol (2007)
43. Dziarski R., and Gupta D. Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect Immun 73 (2005) 5212-5216
44. Martis L., Patel M., Giertych J., Mongoven J., Taminne M., Perrier M.A., et al. Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution. Lancet 365 (2005) 588-594
45. Hashimoto M., Tawaratsumida K., Kariya H., Kiyohara A., Suda Y., Krikae F., et al. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol 177 (2006) 3162-3169
46. von Aulock S., Hartung T., and Hermann C. Comment on "Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus". J Immunol 178 (2007) 2610-2611
47. Into T., Kanno Y., Dohkan J., Nakashima M., Inomata M., Shibata K., et al. Pathogen recognition by Toll-like receptor 2 activates Weibel-Palade body exocytosis in human aortic endothelial cells. J Biol Chem 282 (2007) 8134-8141
48. Andreakos E., Sacre S.M., Smith C., Lundberg A., Kiriakidis S., Stonehouse T., et al. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 103 (2004) 2229-2237